Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baicapil is a synergistic botanical complex designed to combat hair loss and stimulate hair growth. Developed by Provital, it consists of a combination of *Scutellaria baicalensis* root extract, *Triticum vulgare* (wheat) sprout extract, and *Glycine soja* (soy) sprout extract, often formulated with arginine. The mechanism of action involves increasing the ratio of hair in the anagen phase versus the telogen phase, thereby extending the hair growth cycle and improving hair density. It works by stimulating the metabolic activity of the dermal papilla cells, increasing cellular energy (ATP) production, and protecting the hair follicle from oxidative stress and senescence. It is primarily used as an active ingredient in topical formulations for androgenetic alopecia and general hair thinning.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baicapil.